Binding symmetry and surface flexibility mediate antibody self-association
Joseph D. Schrag,
Marie-Ève Picard,
Francis Gaudreault,
Louis-Patrick Gagnon,
Jason Baardsnes,
Mahder S. Manenda,
Joey Sheff,
Christophe Deprez,
Cassio Baptista,
Hervé Hogues,
John F. Kelly,
Enrico O. Purisima,
Rong Shi,
Traian Sulea
Affiliations
Joseph D. Schrag
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Marie-Ève Picard
Département de Biochimie, de Microbiologie et de Bio-informatique, PROTEO, and Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Pavillon Charles-Eugène-Marchand, Québec City, QC G1V 0A6, Canada
Francis Gaudreault
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Louis-Patrick Gagnon
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Jason Baardsnes
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Mahder S. Manenda
Département de Biochimie, de Microbiologie et de Bio-informatique, PROTEO, and Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Pavillon Charles-Eugène-Marchand, Québec City, QC G1V 0A6, Canada
Joey Sheff
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada
Christophe Deprez
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Cassio Baptista
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Hervé Hogues
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
John F. Kelly
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada
Enrico O. Purisima
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Rong Shi
Département de Biochimie, de Microbiologie et de Bio-informatique, PROTEO, and Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Pavillon Charles-Eugène-Marchand, Québec City, QC G1V 0A6, Canada
Traian Sulea
Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada
Solution stability is an important factor in the optimization of engineered biotherapeutic candidates such as monoclonal antibodies because of its possible effects on manufacturability, pharmacology, efficacy and safety. A detailed atomic understanding of the mechanisms governing self-association of natively folded protein monomers is required to devise predictive tools to guide screening and re-engineering along the drug development pipeline. We investigated pairs of affinity-matured full-size antibodies and observed drastically different propensities to aggregate from variants differing by a single amino-acid. Biophysical testing showed that antigen-binding fragments (Fabs) from the aggregating antibodies also reversibly associated with equilibrium dissociation constants in the low-micromolar range. Crystal structures (PDB accession codes 6MXR, 6MXS, 6MY4, 6MY5) and bottom-up hydrogen-exchange mass spectrometry revealed that Fab self-association occurs in a symmetric mode that involves the antigen complementarity-determining regions. Subtle local conformational changes incurred upon point mutation of monomeric variants foster formation of complementary polar interactions and hydrophobic contacts to generate a dimeric Fab interface. Testing of popular in silico tools generally indicated low reliabilities for predicting the aggregation propensities observed. A structure-aggregation data set is provided here in order to stimulate further improvements of in silico tools for prediction of native aggregation. Incorporation of intermolecular docking, conformational flexibility, and short-range packing interactions may all be necessary features of the ideal algorithm.